DABI-ADP-2: Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Dabigatran etexilate (Primary) ; Phenprocoumon
- Indications Embolism; Stroke; Venous thromboembolism
- Focus Therapeutic Use
- Acronyms Dabi-ADP-2
- 10 Jun 2017 Biomarkers information updated
- 01 Jul 2013 Planned End Date changed from 1 Mar 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
- 24 Apr 2012 Planned end date changed from 1 Mar 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.